Generative protein design

Biotechnology & Synthetic BiologyUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

96 papers

Active filtersClassification:Core

Showing 13-24 of total 96 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

AlloPool is a deep learning framework that infers protein allostery from molecular dynamics simulations.

Marfoglia M; Pedraza-Joya MA; Guirardel L; Chatzi Souleiman A; Barth P

Jan 1, 2026

2026PubMedDirectly related

Engineering carboxyl methyltransferase for high-efficiency biosynthesis of methyl salicylate in Escherichia coli.

Gao Y; Guo S; Wu J; Wang J; Liu H; Guo J; Sun X; Wang J; Shen X; Yuan Q

Jan 1, 2026Bioresource technology

2026PubMedSupporting evidence

Ursolic acid attenuates LPS-induced cognitive dysfunction through the modulation of oxidative stress, neuroinflammation, and hippocampal synaptic plasticity.

Choi GY; Lee S; Je AR; Choi H; Moon E; Cho E; Kwon SH; Lee KB; Kweon HS

Jan 1, 2026Phytomedicine : international journal of phytotherapy and phytopharmacology

2026PubMedDirectly related

Computational methods for alternative proteins.

Vyshnav S; Sundararajan V; Sudhakaran SL

Jan 1, 2026Advances in protein chemistry and structural biology

2026PubMedDirectly related

RNAi-based therapeutics targeting the F gene in human metapneumovirus: An in-silico approach.

Ghosh P; Islam MN; Hossain S; Akter A; Munni NA; Miah MA; Tawhid M; Mia ME

Jan 1, 2026Journal, genetic engineering & biotechnology

2026PubMedDirectly related

MiLaSol: modeling protein solubility by mixing up multiple protein language models.

Lou W; Erden M; Cowen L

Jan 1, 2026Bioinformatics advances

2026PubMedDirectly related

Artificial Intelligence for Natural Products Discovery and Development.

Wang W; Xu Z; Lin Y; Liao J

Jan 1, 2026Current topics in medicinal chemistry

2026PubMedDirectly related

Structural Foundation of CTLA-4 antibodies: Emerging Platforms for Next-generation Cancer Immunotherapy.

Leta EM; Syed S; Binegde GN; Gu D; Xiong J; Wang F

Jan 1, 2026International immunopharmacology

2026PubMedDirectly related

Defect-Engineered Tetragonal ZrO2 Nanoparticles for Biomaterial Interfaces: Green Synthesis, Biointerfacial Interactions, and SERS Biosensing.

Proniewicz E; Surma O; Gajewska M; Molenda M

Jan 1, 2026ACS biomaterials science & engineering

2026PubMedSupporting evidence

Structural Overview of GLP-1 Analogs.

van der Velden WJC; Andresen AF; Rosenkilde MM

Jan 1, 2026Biomedical journal

2026PubMedDirectly related

Architectural Design of Phage-Displayed Peptide Libraries for Peptide Discovery.

Ling BL; Peng H; Lim TS

Jan 1, 2026Biotechnology and bioengineering

2026PubMedDirectly related

Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision.

Sriwidodo S; Suhandi C; Sagitasa S; Davinali BAA; Maksum IP; Safuan S

Jan 1, 2026International journal of pharmaceutics: X